Niagen Bioscience (NasdaqCM:CDXC) FY Conference Transcript

Niagen Bioscience (NasdaqCM:CDXC) FY Conference January 15, 2026 11:30 AM ET Company ParticipantsRob Fried - CEOBen Shamsian - VPAdam Lowensteiner - VPConference Call ParticipantsNone - AnalystAllen Klee - AnalystBen ShamsianHello, and welcome to Niagen Bioscience's company webcast. My name is Ben Shamsian, Vice President of Lytham Partners, and today we have Rob Fried, CEO of Niagen, who will be taking us through a brief slide presentation followed by a fireside chat moderated by me. Niagen trades under th ...